Volume 27, Issue 2 pp. 111-117

Identifying cutaneous allodynia in chronic migraine using a practical clinical method

A Ashkenazi

Corresponding Author

A Ashkenazi

Department of Neurology, Thomas Jefferson University and Jefferson Headache Center, Jefferson University Hospital, Philadelphia, PA and

Avi Ashkenazi MD, Department of Neurology, Jefferson Headache Center, Jefferson University Hospital, 111 South 11th Street, Suite 8130, Philadelphia, PA 19107, USA. E-mail [email protected]Search for more papers by this author
M Sholtzow

M Sholtzow

Department of Neurology, Thomas Jefferson University and Jefferson Headache Center, Jefferson University Hospital, Philadelphia, PA and

Search for more papers by this author
JW Shaw

JW Shaw

Department of Neurology, Thomas Jefferson University and Jefferson Headache Center, Jefferson University Hospital, Philadelphia, PA and

Search for more papers by this author
R Burstein

R Burstein

Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center and Program in Neuroscience, Harvard Medical School, Boston, MA, USA

Search for more papers by this author
WB Young

WB Young

Department of Neurology, Thomas Jefferson University and Jefferson Headache Center, Jefferson University Hospital, Philadelphia, PA and

Search for more papers by this author
First published: 02 January 2007
Citations: 13

Abstract

Cutaneous allodynia is common in migraine. In the majority of previous studies on allodynia in migraine, only patients with episodic migraine (EM) were included. Little is known on patterns of allodynia in chronic migraine (CM). Since the presence of allodynia is associated with a poor response to triptans, a clinically practical method to test migraine patients for allodynia would be useful to the clinician. The aim of this study was to assess the prevalence of dynamic mechanical (brush) allodynia (BA) in CM, using a clinically practical method. Eighty-nine CM patients were prospectively recruited. Patients were given a structured questionnaire regarding demographic data and migraine characteristics. Allodynia was tested using a 10 × 10-cm gauze pad to brush various areas of the skin lightly. The prevalence of BA in the entire study population and in different patient subgroups was calculated. BA was present in 42.7% (38/89) of the patients. The presence of allodynia was unrelated to age, disease duration or to the occurrence of an acute headache exacerbation at the time of testing. Allodynia was positively associated with a history of migraine aura. BA was most common in the cephalic area, but was also seen in cervical dermatomes. BA is common in CM and, unlike in EM, is not significantly affected by the occurrence of an acute headache exacerbation. This suggests that central trigeminovascular neurons are chronically sensitized in patients experiencing migraine headache >15 days per month. The testing of BA in the clinical setting is possible using a simple and brief approach. It allows the clinician to determine whether the patient is sensitized, a diagnosis that affects treatment decisions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.